Vivo Ventures V, LLC
CIK 1399028 · last filed 2019-11-25
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
7
Total Filings
18
Lifetime Open-Market Net
-$30.90M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SOLENO THERAPEUTICS INC (SLNO) Delisted | 10%+ Owner | 245,727 | $53.01 | $13.03M | -$931.9K | 3 | 2019-11-25 |
| SOLENO THERAPEUTICS INC (SLNOW) Delisted | 10%+ Owner | 4,219,504 | — | — | $6.00M | 4 | 2018-08-09 |
| SOLENO THERAPEUTICS INC (CAPNW) Delisted | 10%+ Owner | 179,260 | — | — | $0 | 1 | 2017-04-14 |
| Sagent Pharmaceuticals, Inc. (SGNT) Delisted | 10%+ Owner | 2,978,803 | — | — | -$34.44M | 2 | 2016-04-25 |
| SOLENO THERAPEUTICS INC (CAPN.W) Delisted | 10%+ Owner | 6,922,123 | — | — | $0 | 1 | 2016-02-09 |
| Lite Strategy, Inc. (MEIP) Delisted | 10%+ Owner | 9,645 | $3.20 | $30.9K | -$1.53M | 5 | 2015-11-09 |
| ALBIREO PHARMA, INC. (BIOD) Delisted | 10%+ Owner | 56,188 | — | — | $0 | 1 | 2007-05-18 |
Recent Filings · Page 2 of 2
18 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-02-09 | SOLENO THERAPEUTICS INC (CAPN.W) Delisted | Other (J) | +408,672 | $0 | EDGAR |
| 2015-11-09 | Lite Strategy, Inc. (MEIP) Delisted | Sell (S) | −22,693 | -$41.9K | EDGAR |
| 2015-03-26 | Lite Strategy, Inc. (MEIP) Delisted | O | +26,445 | $82.5K | EDGAR |
| 2013-10-29 | Lite Strategy, Inc. (MEIP) Delisted | Sell (S) | −52,221 | -$428.9K | EDGAR |
| 2013-10-03 | Lite Strategy, Inc. (MEIP) Delisted | Sell (S) | −101,382 | -$1.03M | EDGAR |
| 2013-09-17 | Sagent Pharmaceuticals, Inc. (SGNT) Delisted | Sell (S) | −1,617,051 | -$34.36M | EDGAR |
| 2013-05-20 | Lite Strategy, Inc. (MEIP) Delisted | Sell (S) | −3,036 | -$27.5K | EDGAR |
| 2007-05-18 | ALBIREO PHARMA, INC. (BIOD) Delisted | Conv (C) | +1,078,933 | $0 | EDGAR |
Showing 11–18 of 18
Prev
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.